DANAHER CORP /DE/

Public Equity (NYSE)Public EquityNYSELife Sciences

📍 Washington, DC, USA• Founded 1969• 80,000+ employees

StreetZero Signal 67

Be the first to signal interest

About DANAHER CORP /DE/

Danaher Corporation is a global science and technology company that designs, manufactures and markets products and services in life sciences, diagnostics and environmental & applied solutions. It operates through multiple segments serving customers in healthcare, research and industrial markets worldwide. The company is publicly traded on the NYSE under ticker DHR.

LATEST FUNDINGRule 144

$7.0M

Announced 2026-10-28

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for DANAHER CORP /DE/.

Create free account Sign in

Free plan includes 3 full deal profiles every month.

EMPLOYEES80,000+

FOUNDED1969

HQWashington, DC, USA

Industry

Public Equity (NYSE)

Investors

Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.

Key highlights

Completed $7M Rule 144 placement
Publicly traded on NYSE
Headquartered in Washington DC

Ask StreetZero about DANAHER CORP /DE/

Put our AI to work on this deal.

What is DANAHER CORP /DE/'s value proposition?Who are DANAHER CORP /DE/'s competitors?Why does this raise matter?Summarize DANAHER CORP /DE/ for an investor.

Similar companies

Other Public Equity (NYSE) deals, ranked by Signal.

Snowflake Inc.

$94.9M

CAPITAL ONE FINANCIAL CORPORATION

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.